These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases. Lu FM; Yuan Z Quant Imaging Med Surg; 2015 Jun; 5(3):433-47. PubMed ID: 26029646 [TBL] [Abstract][Full Text] [Related]
30. Visualization of Motor Cortex Involvement by 18F-THK5351 PET Potentially Strengthens Diagnosis of Amyotrophic Lateral Sclerosis. Saitoh Y; Imabayashi E; Mukai T; Matsuda H; Takahashi Y Clin Nucl Med; 2021 Mar; 46(3):243-245. PubMed ID: 33323735 [TBL] [Abstract][Full Text] [Related]
31. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. Lavisse S; Guillermier M; Hérard AS; Petit F; Delahaye M; Van Camp N; Ben Haim L; Lebon V; Remy P; Dollé F; Delzescaux T; Bonvento G; Hantraye P; Escartin C J Neurosci; 2012 Aug; 32(32):10809-18. PubMed ID: 22875916 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains. Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244 [TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline. Sturm S; Forsberg A; Nave S; Stenkrona P; Seneca N; Varrone A; Comley RA; Fazio P; Jamois C; Nakao R; Ejduk Z; Al-Tawil N; Akenine U; Halldin C; Andreasen N; Ricci B Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):382-391. PubMed ID: 27633250 [TBL] [Abstract][Full Text] [Related]
34. Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO. Narayanaswami V; Dahl K; Bernard-Gauthier V; Josephson L; Cumming P; Vasdev N Mol Imaging; 2018; 17():1536012118792317. PubMed ID: 30203712 [TBL] [Abstract][Full Text] [Related]
35. How far is arterial spin labeling MRI from a clinical reality? Insights from arterial spin labeling comparative studies in Alzheimer's disease and other neurological disorders. Zhang J J Magn Reson Imaging; 2016 May; 43(5):1020-45. PubMed ID: 26250802 [No Abstract] [Full Text] [Related]
36. An Overview of Astrocyte Responses in Genetically Induced Alzheimer's Disease Mouse Models. Spanos F; Liddelow SA Cells; 2020 Nov; 9(11):. PubMed ID: 33158189 [TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system. Ni R; Mu L; Ametamey S Acta Pharmacol Sin; 2019 Mar; 40(3):351-357. PubMed ID: 29921889 [TBL] [Abstract][Full Text] [Related]
38. Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease. Janssen B; Mach RH Prog Mol Biol Transl Sci; 2019; 165():371-399. PubMed ID: 31481170 [TBL] [Abstract][Full Text] [Related]
39. Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis. Matthews PM; Datta G Expert Opin Drug Discov; 2015 May; 10(5):557-70. PubMed ID: 25843125 [TBL] [Abstract][Full Text] [Related]
40. Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease. Roussakis AA; Piccini P Int Rev Neurobiol; 2018; 141():347-363. PubMed ID: 30314603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]